A fluorescence-based fiber optic measurement system has been developed for monitoring pH, pco2, and p02 through a 20-gauge radial artery catheter without compromising capabilities for monitoring arterial pressure or for blood withdrawal. The measuring probe consists of three optical fibers to which the sensing chemistries are attached, and a thermocouple that measures temperature. The probe is designed to meet in-vivo biocompatibility requirements for a one-time use of up to 72 h. The components that are in contact with the patient's blood are nontoxic, nonhemolytic, nonthrombogenic, and sterilizable. Blood compatibility is enhanced by including covalently bound heparin. The in-vitro accuracy of the system has been tested against commercial blood-gas measurement instruments; comparison with tonometry and blood gas values gave r 0.98 for all three sensors. The standard error for all sensors was within the College of American Pathologists' accuracy guidelines for measuring blood gas. Instrumental drift was minimal, indicating that system performance characteristics should not be the limiting factor in obtaining clinically useful information for up to 72 h. The assessment of p02, Pco2, and pH in arterial blood has come to be regarded as an essential tool in the diagnosis and treatment of patients in intensive-care units and in surgery. With current sampling and measurement techniques, bloodgas information is usually obtained from intensive care units, on a scheduled basis (usually every 2, 4, or 8 h); furthermore, owing to the time needed to transport and analyze the sample, the blood-gas values reflect what the patient's status was 5 to 20 mm before the blood-gas results are received. For patients in unstable conditions, it would be desirable to have current blood-gas information available continuously, particularly when a crisis occurs, or when the adequacy of therapeutic intervention is being assessed.
these is capable of measuring all three blood-gas analytes. In addition, the noninvasive transcutaneous method suffers from poor accuracy under certain conditions, particularly in adults. When peripheral circulation is diminished, the correlation between transcutaneous measurements and bloodgas values is often poor. The noninvasive oxygen saturation method is unable to discriminate between partial pressures for oxygen once the blood is nearly saturated (saturation >96%). The need for a truly continuous monitor of intravascular blood gas that can provide accurate information throughout the clinically useful concentration range has led to the development of the CDIT" System 1000 (Cardiovascular Devices, Inc., Irvine, CA 92714), which we describe here.
Materials and Methods

CDI System 1000
The CDI System 1000 is designed to measure the intraarterial pH, Pco2, and P0, with a disposable fiber-optic probe. The system consists of a portable filter fluorometer, a polemountable display panel, a disposable probe, and a patient interface module to which the disposable probe can be attached.
Filter fluorometer. The fluorometer contains the optical source, filters, power supplies, and microprocessor. The microprocessor converts the signal intensities to O and CO2 partial pressure and pH values, controls the calibrator for automatic two-point calibration, and provides output information to the display panel and RS232 interface. Figure 1 shows a diagram of the optical pathway. A pulsed xenon lamp and a filter wheel containing the appropriate excitation filters launch the excitation light down three fiber-optic cables to the patient-interface module. In the module, a fraction of the light is diverted by the beamsplitter to act as a reference signal. The remainder of the light passes to the individual chemical sensors, where the appropriate fluorescent dyes are excited. The fluorescent output from the dyes is returned via the same fiber to the interface module, where it is diverted by the beanisplitter to the signal detector. After appropriate amplification, the electronic signal is returned to the fluorometer for processing. The connection between the disposable probe and the interface module has been designed to allow for disconnection and reconnection during use with a minimum of change in intensity. When the probe is disconnected, appropriate calibration information is preserved in a nonvolatile RAM device that stays with the probe and is connected to the interface module during use.
Di.sposable probe. The operation of the CDI System 1000 is based on the variation in fluorescence intensity of certain forms have different excitation spectra but a common emission spectrum. Thus, the ratio of the two species, which is independent of absolute lamp intensity and dye concentration, can be used to determine the pH and Pco2 concentrations.
In the pH sensor, the dye is bonded to a hydrophilic matrix and attached directly to the end of a prepared fiber.
In use, the two species of dye are alternately excited by light at 410 and 460 nm. The intensity of light emitted at 520 nm is measured and a ratio of the emitted light from the two species is used to calculate the actual pH at the tip of the sensor.
In the Pco2 sensor, the dye is dissolved in a bicarbonate buffer and encapsulated in silicone. The buffer concentration has been optimized to provide maximum pH change for the physiological range of pco2 values. The measurement of the dye ratio, obtained in a manner similar to that of the pH sensor, is used to calculate the Pco2 partial pressure.
Fluorescent dyes with appropriately long decay constants
are known to be quenched by oxygen; that is, they lose fluorescence intensity in the presence of oxygen in proportion to the partial pressure of oxygen. The P02 sensor in the CDI System 1000 utilizes an oxygen-quenchable dye dissolved in silicone. The intensity of light emitted at 515 nm is inversely proportional to the P02 partial pressure when the dye is excited by 385-nm light of constant intensity.
Each sensor is coated with a permeable opaque film to optically isolate the chemical system from its environment while allowing rapid equilibrium of the appropriate gases and hydrogen ions. Although we did not use the following procedure during these studies, one can recalibrate the system during use by taking a blood-gas sample and adjusting the CDI System =1E:E;,,I::
:::. 1000 blood-gas values to the corresponding blood-gas values determined by routine laboratory analysis.
Accuracy and precision. We used a loop for circulating blood to assess the accuracy of the CDI System 1000 for measuring blood gases in flowing blood. Heparinized bovine blood was circulated in a closed loop by a roller pump. A Bentley B10-5 bubble oxygenator (American Bentley, Irvine, CA 92714) was used to maintain constant temperature via a circulating water bath and to equilibrate the blood with each of the gases of interest. The loop included places for insertion of four catheters, through which we inserted four probes; it also included a stopcock for withdrawal of blood samples for determining pH with a blood-gas analyzer (IL 1304; Instrumentation Laboratory, Lexington, MA). Before this experiment, we added 0.5 moIIL bicarbonate and 20 g/L dextrose solutions to give the bovine blood a final hematocrit of 30%-40%, a sodium ion concentration of 135-141 mmoIlL, and an osmolarity of 290-310 mosmollL.
Animal study. After calibrating the CDI System 1000, we placed the probe into a 20-gauge arterial catheter previously inserted in the right femoral artery of an anesthetized dog. The blood-pressure monitoring and heparin-infusion lines were attached to the probe's Y-connector. The infusion solution, sterile isotonic saline (NaCl, 9 g/L) containing 200 USP units of heparin per liter, was added at about 3 mL/h. We monitored the pulse of the animal before and after inserting the probe into the catheter to assure that the presence of the probe did not decrease the blood pressure values being measured through the catheter. Periodically, we also collected blood samples through a catheter placed in the left carotid artery, and analyzed them with an IL 1301 blood-gas analyzer (Instrumentation Laboratory). A total of 118 0.5-mL blood samples were drawn and analyzed during the 4 h of the experiment.
Interference testing. We testedthe CDI System 1000 for possible interferences from commonly used anesthetic agents by equilibrating the probe in bovine blood, then adding typical doses of the various drugs while keeping all other variables constant. Injectable drugs were added to the blood directly. Tests of anesthetic gases required careful control to maintain constant partial pressures of 02 and CO2 during the test. To introduce nitrous oxide, we used a gas mixer (Model PGM-3; Medicor, Inc., Salt Lake City, UT 84106); halothane concentration was controlled by using flow meters for quantitative dilution of halothane-saturated gas.
Results and Discussion
Instrument Evaluation
Accuracy. The in-vitro accuracy of the system was measured by successively equilibrating the blood loop at each of six 02 and CO2 gas concentrations at 37 #{176}C, then repeating the equilibration of the six gases at 28 #{176}C. We calculated the comparison Pco, and Po values from the percentage composition of each gas, the Lrometric pressure, and the vapor pressure of water at the blood-loop temperature. The cornparison pH values were determined by assaying an equilibrated blood sample in triplicate with an IL 1304 blood-gas analyzer calibrated just before use. Results of this study are shown in Table 1 . The standard errors of the estimate throughout the physiological normal range for pH, pco2, and  P02 are 0.026, 1.9 mmHg, and 3.6 mmllg, respectively. ' These values fall within the criteria limits for good bloodgas analyzer performance: ± 0.03, ± 3 mmHg (or 7.5%), and ± 5 minHg (or 7.5%) for pH, Pco,, and Po2, respectively (4).
In-use stability. Current medical practice suggests that arterial catheters be replaced every 72 h. To test the actual limitations of the System 1000, as related to drift and chemical photodegradation, we calibrated four probes and placed them in a buffer solution equilibrated at 37 #{176}C with gases so as to produce values of 7.30, 44 mmHg, and 65 mmHg for pH, Pco2 and Po, respectively. The systems were run without interruption for eight days. The average total drift for the entire eight days and the average daily drift for each sensor are shown in Table 2 . The extreme stability of the system, exemplified by this data, indicates that the system can routinely be run for more than 72 h and that very few in-vivo recalibrations will be required to maintain clinically acceptable accuracy.
Time response. By using two parallel blood loops we could create a nearly instantaneous step change in the blood-gas values seen by the probe. The time required for the pH, Pco2 and Po, sensors to reach 63% (within lie) of the new equilibrium value under these conditions is defined as the response time (T) of the sensor. Typical response times for the pH, Pco2, and Po, sensors (Figure 3) are 0.6, 1.6, and 1.0 mm, respectively. The time required to begin responding to a step change in blood-gas values defines the system lag time. This interval is influenced by the diffusion rates of the gases and ions to the sensor chemical systems and by the frequency at which the processed information is updated. With its update rate of 2 s and the short diffusion paths in the sensors, the CDI System 1000 is able to begin responding to a step change in blood-gas values virtually as soon as the step change occurs.
Animal Study
During the 4-h dog experiment, we collected 118 0.5-mL blood samples and analyzed them with an IL 1301 blood-gas analyzer. Figure 4 illustrates the time course of the PH, Pco2 and P0, values measured by the System 1000 and the IL 1301. Major increases in Po, values were induced at 60 '1 mmHg -0.133 kPa. Interference from anesthetic agents. The effect of anesthetic agents on the performance of the CDI System 1000 chemistries is tabulated in Table 3 . Halothane at 20 mLIL had a major effect on the P0, sensor, probably as a result of "heavy atom" quenching from the bromine in the halothane molecule. Nitrous oxide concentrations of 600 mL/L had a small effect on all three sensors; this change was probably due to the inability to precisely control gas-mixing precision 
